What Key Growth Drivers Are Shaping The Non-invasive Prenatal Testing Market Forecast Toward $10.86 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Non-invasive Prenatal Testing Market Today And What Is Its Future Size?
The market size for non-invasive prenatal testing has experienced a swift expansion in the past few years. The market is forecasted to escalate from $5.48 billion in 2024 to $6.27 billion in 2025, with a sizeable compound annual growth rate (CAGR) of 14.5%. Factors contributing to the growth during the historic period include heightened accuracy, diminished risk, a rise in maternal age, increasing awareness, and clinical guidelines.
In the coming years, the market size of non-invasive prenatal testing is anticipated to witness swift expansion. It’s projected to reach $10.86 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 14.7%. Factors contributing to this expected surge during the forecast period include an increase in test offerings, greater accessibility, escalating maternal age, detection of fetal anomalies, advancements in telemedicine, and digital health. Notable trends for the forecast time frame cover extended test panels, a broader acceptance of NIPT, technological progress, and non-invasive fetal aneuploidy diagnosis (nifad).
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp
Which Demand Drivers Are Strengthening The Non-invasive Prenatal Testing Market?
The high occurrence rate of Down syndrome primarily propels the non-invasive prenatal testing market, due to the associated rise in average maternal age and resulting concerns regarding fetal safety. Down syndrome, a chromosomal defect due to a cell division error resulting in an extra 21st chromosome, can have a negative impact on the physical and cognitive development of a fetus. Non-invasive prenatal testing (NIPT) poses no harm to the mother or baby and eliminates the risk of miscarriage while being able to detect over 99% of Down syndrome cases. The National Down Syndrome Society and Centres for Disease Control and Prevention state that 1 in every 700 babies born in the US have Down syndrome, and 80% of these children are born to older mothers. This increased possibility of bearing a Down syndrome child among older women propels growth for the non-invasive prenatal testing market.
Which Segment Accounts For The Largest Share In The Non-invasive Prenatal Testing Market?
The non-invasive prenatal testingmarket covered in this report is segmented –
1) By Type: Consumables; Instruments
2) By Application: Trisomy; Microdeletion; Genetics; Rh factor
3) By End User: Hospital; Diagnostic Labs
Subsegments:
1) By Consumables: Assay Kits; Reagents; Disposables
2) By Instruments: Next-Generation Sequencers (NGS); Polymerase Chain Reaction (PCR) Systems; Ultrasound Devices; Others (Microarrays And Mass Spectrometers)
What Strategic Shifts And Innovations Are Influencing The Non-invasive Prenatal Testing Market?
The advancement of next-generation sequencing has significantly improved throughput, scalability, and speed, allowing researchers to conduct a more diverse range of applications and study biological systems more intensively. It’s a platform that facilitates the concurrent sequencing of thousands to millions of DNA molecules. Makers have introduced this technology to decrease the time and cost necessary while maximizing the output to yield results related to genome and DNA testing. Prominent firms like Illumina, Eurofins, Natera, Roche, and Annoroad have adopted this technology in non-invasive prenatal testing. The NGS instrument NextSeq 550AR, produced by Annoroad, has received approval for medical instrument product registration from the CFDA (China Food and Drug Administration).
Which Companies Hold A Competitive Edge In The 1203 Market?
Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
Which Region Is Forecasted To Lead The Non-invasive Prenatal Testing Market In The Coming Years?
North America was the largest region in the non-invasive prenatal testing market in 2024. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=2492&type=smp
Browse Through More Reports Similar to the Global Non-invasive Prenatal Testing Market 2025, By The Business Research Company
Hormonal Contraceptives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Molecular Diagnostics Devices And Equipment Global Market Report 2025
Prenatal Testing And Newborn Screening Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
